Sleep Apnea Device Market to Surpass USD 6.9 Bn Valuation by 2022 | Says MRFR

Aug 16, 2019

Market Research Future (MRFR) Conducted an Elaborate Study on the Global Sleep Apnea Device Market that predicts the Growth of the market with Top Players during the forecast period of 2018-2022.

Pune, India - August 16, 2019 /MarketersMedia/ —

Sleep Apnea Device Market Global Overview:

Sleep apnea is a sleeping disorder with irregular breathing due to internal interruptions. As a result, the brain receives less oxygen and can cause brain damage. Various factors, such as large neck size, enlarged tonsils, obesity, allergies, small jaw bone, sinus problem can trigger sleep apnea. It can also happen hereditarily after 40. Sleep apnea devices assist in normalizing the air intake procedure. The global sleep apnea devices market is slated to rise with a 7.8% CAGR during the forecast period (2016-2022). Market Research Future (MRFR) predicts that the sleep apnea devices market can exceed a valuation of USD 6.9 billion by the end of 2022.

Several factors are expected to take on various global dynamics to ensure better progress for the sleep apnea market. The inclusion of technology in the sector is quite unprecedented and the awareness regarding sleep apnea is on the rise, which can be considered as major influencing factors for the global market. A substantial investment is also taking place in the research and development sector to inspire high growth in innovation and subsequently, it would lead to better market proliferation. Intense competition between major players are also expected to inspire market growth as their strategic battle would bring out the best.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2061

Segmentation:

MRFR in the global sleep apnea device market report segmented the market into type and end-user for a better understanding of the entire market. This segmentation is backed by value-specific and volume-specific data.

Based on the type, the sleep apnea device market comprises therapeutic and diagnostic sleep apnea devices. The therapeutic device includes positive airway pressure (PAP) devices, accessories, oral appliances, adaptive servo-ventilators (ASV), facial interfaces (mask), continuous positive airway pressure (CPAP), and other therapeutic devices that consists oxygen concentrators and airway clearance systems. The therapeutic device in 2016 had the maximum market share. PAP in that segment had control of the market in 2017. The diagnostic device segment includes polysomnographs (PSG) and oximeter.

Based on the end-user, the sleep apnea device market can be segmented into hospitals, sleep laboratories, and home care. The home care/individual segment recorded the fastest growth rate during the forecast period.

Regional Analysis:

Region-specific analysis of the global sleep apnea device market inspires inclusion of regions namely North America, Europe, Asia Pacific (APAC), and the Rest-of-the-World (RoW). Such an analysis facilitates an easy understanding of growth pockets that can play impactful role in taking the global market ahead.

North America’s revenue share is quite great and the regional market is expected to retain the market growth during the forecast period. With hike in awareness regarding sleep apnea, the regional market is all set to earn more revenues. The region is expected to garner substantially from the presence of major market players.

Europe is witnessing high intake of non-invasive and painless cardiorespiratory monitors that is getting thrust for its ability to assess oxygen level in the blood.

The APAC market has high promises as the region is the house of almost half the population of the entire market. At the same time, several emerging economies are now providing alluring opportunities to various market players to expand their business.

Competitive Landscape:

Major players in the global sleep apnea device market are MedTech, Drive Devilbiss Healthcare, Lowenstein Medical, Fisher & Paykel Healthcare Limited, Consumer Sleep Solution LLC, Invacare Corporation, Cadwell Laboratories Inc, Natus Medical Incorporated, Philips Healthcare, Compumedics, Resmed Inc, Koninklijke Philips, SomnoMed, BMC Medical, Nihon Kohden Corporation, and Braebon Medical Corporation. MRFR has put in substantial effort to profile these companies and analyze latest trends to dominate the market.

In July 2019, Resonea Inc.launched DROWZLE Sleep Apnea Pre-screening Device, which got FDA clearance. This prescription medical device has standalone smartphone software to record and analyze patient respiratory patterns to allow telemonitoring for obstructive sleep apnea (OSA). 

Access Full Report at https://www.marketresearchfuture.com/reports/sleep-apnea-devices-market-2061

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/sleep-apnea-devices-market-2061

Source URL: https://marketersmedia.com/sleep-apnea-device-market-to-surpass-usd-69-bn-valuation-by-2022-says-mrfr/88908682

Source: MarketersMedia

Release ID: 88908682

More News

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.